Gene · 55869
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Establishment of a transgene-free iPS cell line (SDQLCHi046-A) from a young patient bearing a HDAC8 mutation and suffering from Cornelia de Lange Syndrome. | Stem Cell Res | 2023 | 36481505 | PubTator, text mining | PubMed |
| White Spot Syndrome Virus (WSSV) Inhibits Hippo Signaling and Activates Yki To Promote Its Infection in Penaeus vannamei. | Microbiol Spectr | 2023 | 36475933 | PubTator, text mining | PubMed |
| Drug resistance in children and adolescents with HIV in Panama. | J Antimicrob Chemother | 2023 | 36454248 | PubTator, text mining | PubMed |
| The developmental trajectories of the behavioral phenotype and neuropsychiatric functioning in Cornelia de Lange and Rubinstein Taybi syndromes: A longitudinal study. | Am J Med Genet A | 2023 | 36373849 | PubTator, text mining | PubMed |
| Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening. | J Biomol Struct Dyn | 2023 | 36369945 | PubTator, text mining | PubMed |
| Cytoplasmic HDAC4 recovers synaptic function in the 3×Tg mouse model of Alzheimer's disease. | Neuropathol Appl Neurobiol | 2023 | 36331820 | PubTator, text mining | PubMed |
| miR-214-5p/C1QTNF1 axis enhances PCV2 replication through promoting autophagy by targeting AKT/mTOR signaling pathway. | Virus Res | 2023 | 36302471 | PubTator, text mining | PubMed |
| Development of a Cellular Model Mimicking Specific HDAC Inhibitors. | Methods Mol Biol | 2023 | 36255617 | PubTator, text mining | PubMed |
| Cornelia de Lange syndrome and cancer: An open question. | Am J Med Genet A | 2023 | 36253936 | PubTator, text mining | PubMed |
| Chemically Diverse S. mansoni HDAC8 Inhibitors Reduce Viability in Worm Larval and Adult Stages. | ChemMedChem | 2023 | 36250286 | PubTator, text mining | PubMed |
| Comprehensive Transcriptomic Analysis of Novel Class I HDAC Proteolysis Targeting Chimeras (PROTACs). | Biochemistry | 2023 | 35948047 | PubTator, text mining | PubMed |
| Design of Protein Segments and Peptides for Binding to Protein Targets. | Biodes Res | 2022 | 37850124 | PubTator, text mining | PubMed |
| Palmitic acid declines glucose uptake in HepG2 cells via modulating phosphoglucomutase 1 to repress phosphatidylinositol 3 kinase/protein kinase B and JNK pathways via inducing microRNA-124-3p. | Turk J Biol | 2022 | 37529096 | PubTator, text mining | PubMed |
| Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy. | Front Oncol | 2022 | 36761420 | PubTator, text mining | PubMed |
| A New Frontier in Studying Dietary Phytochemicals in Cancer and in Health: Metabolic and Epigenetic Reprogramming. | Prev Nutr Food Sci | 2022 | 36721757 | PubTator, text mining | PubMed |
| The role of altered protein acetylation in neurodegenerative disease. | Front Aging Neurosci | 2022 | 36688174 | PubTator, text mining | PubMed |
| HAT- and HDAC-Targeted Protein Acetylation in the Occurrence and Treatment of Epilepsy. | Biomedicines | 2022 | 36672596 | PubTator, text mining | PubMed |
| Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets. | Mar Drugs | 2022 | 36662197 | PubTator, text mining | PubMed |
| Medicinal Chemistry of Anti-HIV-1 Latency Chemotherapeutics: Biotargets, Binding Modes and Structure-Activity Relationship Investigation. | Molecules | 2022 | 36615199 | PubTator, text mining | PubMed |
| Genomics and Epigenomics in the Molecular Biology of Melanoma-A Prerequisite for Biomarkers Studies. | Int J Mol Sci | 2022 | 36614156 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55869/papers?page=25